At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,604 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Family Blood Pressure Program - HyperGEN
In Brief
An observational study for Cardiovascular Diseases and 2 related conditions. Completed, enrolled 3,604 participants.
Detailed Summary
To map and identify the major genetic determinants of hypertension and to study possible interactions between genetic and non-genetic factors in defined populations. HyperGEN initially consisted of a nine grant network, which in turn is part of an NHLBI initiative, the Family Blood Pressure Program (FBPP) consisting of four networks.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Hypertension
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 1995
First PostedMay 2000
Primary CompletionAug 2008
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartSep 1, 1995
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 12.9 yearsPosted 26.1 years ago